COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2 Data further strengthens value proposition of BiondVax’s COVID-19 NanoAb as prophylactic and…
Immunocompromised Individuals, Including Organ Transplant Recipients, are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Existing EUA-Approved Therapeutic Monoclonal Antibody Therapies…
Taking this in mind, the study team tested the efficacy of small molecule inhibitors that target fatty acid metabolism and VPS34 for anti-SARS-CoV-2 activity. They proved to be powerful inhibitors of SARS-CoV-2 replication. They also…